TNFα promotes proliferation of oligodendrocyte progenitors and remyelination
Abstract
Here we used mice lacking tumor necrosis factor-alpha (TNF alpha) and its associated receptors to study a model of demyelination and remyelination in which these events could be carefully controlled using a toxin, cuprizone. Unexpectedly, the lack of TNF alpha led to a significant delay in remyelination as assessed by histology, immunohistochemistry for myelin proteins and electron microscopy coupled with morphometric analysis. Failure of repair correlated with a reduction in the pool of proliferating oligodendrocyte progenitors (bromodeoxyuridine-labeled NG2(+) cells) followed by a reduction in the number of mature oligodendrocytes. Analysis of mice lacking TNF receptor 1 (TNFR1) or TNFR2 indicated that TNFR2, not TNFR1, is critical to oligodendrocyte regeneration. This unexpected reparative role for TNF alpha in the CNS is important for understanding oligodendrocyte regeneration/proliferation, nerve remyelination and the design of new therapeutics for demyelinating diseases.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The debris-clearing function of myeloid cells and mediators released from innate immune cells stimulate remyelination.
“This aligns with the notion that the debris-clearing function of myeloid cells and mediators released from innate immune cells stimulate remyelination.61-63”
From BCAS1-positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis (2025) · cites this paper as [61]
SJL mice demyelinate partially at midline, whereas C57BL/6 mice show robust demyelination, particularly at week 5.
“We found SJL mice demyelinate partially at midline (Figure 2A), whereas C57BL/6 mice show robust demyelination, particularly at week 5 2, 23, 35.”
From SJL Mice Exposed to Cuprizone Intoxication Reveal Strain and Gender Pattern Differences in Demyelination (2009) · cites this paper as [2]
C57BL/6 mice showed greater than 50% remyelination within 2 weeks of discontinuation of cuprizone.
“C57BL/6 mice showed greater than 50% remyelination within 2 weeks of discontinuation of cuprizone 2, 42, which is in stark contrast to the reduced remyelination reported here for SJL.”
From SJL Mice Exposed to Cuprizone Intoxication Reveal Strain and Gender Pattern Differences in Demyelination (2009) · cites this paper as [2]
The increased severity in EAE may be because of T-cell immune mechanisms that are not induced by cuprizone intoxication.
“The increased severity in EAE may be because of T‐cell immune mechanisms that are not induced by cuprizone intoxication 2, 24.”
From SJL Mice Exposed to Cuprizone Intoxication Reveal Strain and Gender Pattern Differences in Demyelination (2009) · cites this paper as [2]
Unlike microglia and astrocytes in C57BL/6 mice that respond vigorously to demyelination, these cell types in SJL mice have a guarded response at midline and in the lateral region, which correlates with subdued demyelination.
“Thus, unlike microglia and astrocytes in C57BL/6 mice that respond vigorously to demyelination 2, 23, 39, these cell types in SJL mice have a guarded response at midline and in the lateral region, which correlates with subdued demyelination.”
From SJL Mice Exposed to Cuprizone Intoxication Reveal Strain and Gender Pattern Differences in Demyelination (2009) · cites this paper as [2]
TNF expression levels are increased after one week of cuprizone-induced demyelination in vivo, and TNFα−/− mice showed a delay in demyelination, consistent with a role for TNF to exacerbate cuprizone-induced demyelination.
“TNF expression levels are increased after one week of cuprizone-induced demyelination in vivo [224] and TNFα−/− mice showed a delay in demyelination in the cuprizone model [56], consistent with a role for TNF to exacerbate cuprizone-induced demyelination.”
From Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination (2022) · cites this paper as [224]
TNF is also required for remyelination.
“However, TNF is also required for remyelination [224].”
From Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination (2022) · cites this paper as [224]
Cuprizone-induced de- and remyelination are not mediated by B or T cells.
“Overall, cuprizone-induced de- and remyelination are not mediated by B or T cells, as shown by the use of RAG −/− mice that lack lymphocytes (Arnett et al., 2001; Hiremath et al., 2008).”
From Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned (2014) · cites this paper as Arnett et al., 2001
In the cuprizone model, TNF-α acts in a bivalent manner, since TNF-α−/− mice displayed reduced loss of oligodendrocytes during the first 3.5 weeks of cuprizone feeding but also a significantly diminished ability to remyelinate.
“In the cuprizone model, TNF-α was demonstrated to act as well in a bivalent manner since TNF-α −/− mice displayed a reduced loss of oligodendrocytes during the first 3.5 weeks of cuprizone feeding but also a significantly diminished ability to remyelinate (Arnett et al., 2001).”
From Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned (2014) · cites this paper as Arnett et al., 2001
TNFR2−/− mice displayed diminished/delayed regeneration of myelin.
“Furthermore, similar to TNF-α-deficient mice TNFR2 −/− mice displayed diminished/delayed regeneration of myelin”
From Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned (2014) · cites this paper as Arnett et al., 2001
TNFR2 but not TNFR1 was gradually up-regulated during de- and remyelination.
“In this study TNFR2 but not TNFR1 has been shown to be gradually up-regulated during de- and remyelination (Arnett et al., 2001).”
From Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned (2014) · cites this paper as Arnett et al., 2001
An adequate and controlled inflammatory response is required for successful myelin regeneration, promoting clearance of myelin debris and stimulating proliferation/regeneration of myelin-forming oligodendrocytes.
“However, a growing body of evidence corroborates the assumption that an adequate and controlled inflammatory response is required for a successful myelin regeneration promoting the clearance of myelin debris and stimulating proliferation/regeneration of myelin-forming oligodendrocytes (Diemel et al., 1998; Robinson and Miller, 1999; Arnett et al., 2001; Kotter et al., 2001, 2005, 2006; Setzu et al”
From Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned (2014) · cites this paper as Arnett et al., 2001
Beneficial effects of TNF-α on proliferation of OPC and subsequent remyelination are promoted through the TNFR2 pathway.
“suggesting that beneficial effects of TNF-α on proliferation of OPC and subsequent remyelination are promoted through the TNFR2 pathway (Arnett et al., 2001).”
From Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned (2014) · cites this paper as Arnett et al., 2001
Functional studies using RAG-1-/- mice suggest that recruited CD3+ lymphocytes do not play a major role during cuprizone-induced demyelination and subsequent endogenous remyelination.
“Functional studies using recombinase activating gene-1 knockout (RAG-1 -/-) mice suggest that the recruited CD3 + lymphocytes do not play a major role during cuprizone-induced demyelination and the subsequent endogenous remyelination process (Arnett et al., 2001;Bieber et al., 2003;Hiremath et al., 2008).”
From Cuprizone‐induced demyelination triggers a <scp>CD8</scp>‐pronounced T cell recruitment (2021) · cites this paper as Arnett et al., 2001
IL-1beta and TNF-alpha can be harmful for cerebral elements but also play beneficial roles in the inflammatory response.
“Such cytokines can thus be harmful for the cerebral elements (138) but they also play beneficial roles in the inflammatory response (161–163).”
From The HPA – Immune Axis and the Immunomodulatory Actions of Glucocorticoids in the Brain (2014) · cites this paper as [161]
Cites
The TNF and TNF Receptor Superfamilies
Locksley, R. M., Killeen, N., & Lenardo, M. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00237-9 · Cited by 3,650 · see citing works
Apoptosis control by death and decoy receptors
Ashkenazi, A., & Dixit, V. M. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80034-9 · Cited by 1,281 · see citing works
Pasparakis, M., Alexopoulou, L., Episkopou, V., & Kollias, G. A. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.4.1397 · Cited by 1,160 · see citing works
The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group (1999) · Neurology · doi:10.1212/wnl.53.3.457 · Cited by 1,060 · see citing works
Matsushima, G. K., & Morell, P. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00385.x · Cited by 984 · see citing works
Self-citationIdentification of autoantibodies associated with myelin damage in multiple sclerosis
Genain, C. P., Cannella, B., Hauser, S. L., & Raine, C. S. (1999) · Nature Medicine · doi:10.1038/5532 · Cited by 891 · see citing works
Characterization of tumor necrosis factor-deficient mice
Marino, M. W., Dunn, A. R., Grail, D., Inglese, M., Noguchi, Y., Richards, E. A., Jungbluth, A., Wada, H., Moore, M. A. S., Williamson, B., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8093 · Cited by 767 · see citing works
Self-citationvan Oosten, B. W., Barkhof, F., Truyen, L., Boringa, J., Bertelsmann, F. W., Blomberg, B. M. E. V., Woody, J. N., Hartung, H., & Polman, C. H. (1996) · Neurology · doi:10.1212/wnl.47.6.1531 · Cited by 735 · see citing works
Ruddle, N. H., Bergman, C. M., McGrath, K. M., Lingenheld, E. G., Grunnet, M. L., Padula, S. J., & Clark, R. B. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.172.4.1193 · Cited by 689 · see citing works
Coetzee, T., Fujita, N., Dupree, J. L., Shi, R., Blight, A. R., Suzuki, K., Suzuki, K., & Popko, B. (1996) · Cell · doi:10.1016/s0092-8674(00)80093-8 · Cited by 624 · see citing works
Self-citationAtlas of the Mouse Brain and Spinal Cord
Sidman, R. L., Angevine, J. B., & Pierce, E. T. (1971) · Cited by 578 · see citing works
Nait‐Oumesmar, B., Decker, L., Lachapelle, F., Avellana‐Adalid, V., Bachelin, C., & Van Evercooren, A. B. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00873.x · Cited by 560 · see citing works
TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination
Liu, J., Marino, M. W., Wong, G., Grail, D., Dunn, A. R., Bettadapura, J., Slavin, A., Old, L. J., & Bernard, C. C. A. (1998) · Nature Medicine · doi:10.1038/nm0198-078 · Cited by 548 · see citing works
Self-citationEndogenous progenitors remyelinate demyelinated axons in the adult CNS
Gensert, J. M., & Goldman, J. E. (1997) · Neuron · doi:10.1016/s0896-6273(00)80359-1 · Cited by 544 · see citing works
ATLAS OF THE MOUSE BRAIN AND SPINAL CORD
Strich, S. J. (1972) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.35.3.422-b · Cited by 538 · see citing works
Interleukin-1β Promotes Repair of the CNS
Mason, J. L., Suzuki, K., Chaplin, D. D., & Matsushima, G. K. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-18-07046.2001 · Cited by 502 · see citing works
Self-citationSmall, R. K., Riddle, P. N., & Noble, M. A. (1987) · Nature · doi:10.1038/328155a0 · Cited by 474 · see citing works
Dual role of tumor necrosis factor alpha in brain injury.
Shohami, E., Ginis, I., & Hallenbeck, J. (1999) · Cytokine & growth factor reviews · doi:10.1016/s1359-6101(99)00008-8 · Cited by 443 · see citing works
Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice
Hiremath, M. M., Saito, Y., Knapp, G. W., Ting, J. P.-Y., Suzuki, K., & Matsushima, G. K. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00168-4 · Cited by 412 · see citing works
Self-citationRole of Lymphotoxin and the Type I TNF Receptor in the Formation of Germinal Centers
Matsumoto, M., Mariathasan, S., Nahm, M. H., Baranyay, F., Peschon, J. J., & Chaplin, D. (1996) · Science · doi:10.1126/science.271.5253.1289 · Cited by 374 · see citing works
A crucial role for neurotrophin-3 in oligodendrocyte development
Barres, B. A., RAFF, M. C., Gaese, F., Bartke, I., Dechant, G., & Barde, Y. (1994) · Nature · doi:10.1038/367371a0 · Cited by 357 · see citing works
Kassiotis, G., & Kollias, G. A. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.4.427 · Cited by 332 · see citing works
Akassoglou, K., Bauer, J., Kassiotis, G., Pasparakis, M., Lassmann, H., Kollias, G. A., & Probert, L. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65622-2 · Cited by 316 · see citing works
(1978) · PubMed · Cited by 297 · see citing works
Körner, H., Riminton, S., Strickland, D. H., Lemckert, F. A., Pollard, J. D., & Sedgwick, J. D. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1585 · Cited by 239 · see citing works
Nishiyama, A., Lin, X., Giese, N. A., Heldin, C., & Stallcup, W. B. (1996) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19960201)43:3 · Cited by 239 · see citing works
Gene Expression in Brain during Cuprizone-Induced Demyelination and Remyelination
Morell, P., Barrett, C. V., Mason, J. L., Toews, A. D., Hostettler, J. D., Knapp, G. W., & Matsushima, G. K. (1998) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1998.0715 · Cited by 213 · see citing works
Self-citationDopp, J. M., MacKenzie‐Graham, A. J., Otero, G. C., & Merrill, J. E. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00009-x · Cited by 207 · see citing works
Proliferation of mature oligodendrocytes after trauma to the central nervous system
Ludwin, S. K. (1984) · Nature · doi:10.1038/308274a0 · Cited by 178 · see citing works
Haridas, V., Darnay, B. G., Natarajan, K., Heller, R. A., & Aggarwal, B. B. (1998) · PubMed · Cited by 159 · see citing works
Delayed Changes in Growth Factor Gene Expression during Slow Remyelination in the CNS of Aged Rats
Hinks, G. L., & Franklin, R. J. M. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0897 · Cited by 156 · see citing works
The Role of Oligodendrocytes and Oligodendrocyte Progenitors in cns Remyelination
Keirstead, H. S., & Blakemore, W. F. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4685-6_15 · Cited by 150 · see citing works
Declercq, W., Denecker, G., Fiers, W. C., & Vandenabeele, P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.1.390 · Cited by 145 · see citing works
Haridas, V., Darnay, B. G., Natarajan, K., Heller, R. A., & Aggarwal, B. B. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3152 · Cited by 136 · see citing works
Weiß, T., Grell, M., Siemienski, K., Mühlenbeck, F., Dürkop, H., Pfizenmaier, K., Scheurich, P., & Wajant, H. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.3136 · Cited by 134 · see citing works
Cytokine regulation of secondary lymphoid organ development
Chaplin, D., & Fu, Y. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80167-2 · Cited by 121 · see citing works
Tansey, F. A., & Cammer, W. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb02104.x · Cited by 120 · see citing works
(1979) · PubMed · Cited by 117 · see citing works
Self-citationMiller, D. J., Sanborn, K. S., Katzmann, J., & Rodriguez, M. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-10-06230.1994 · Cited by 102 · see citing works
Origin of Oligodendrocytes within the Human Spinal Cord
Hajihosseini, M. K., Tham, T. N., & Dubois-Dalcq, M. E. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-24-07981.1996 · Cited by 94 · see citing works
Wu, J.-P., Kuo, J., Liu, Y.-L., & Tzeng, S. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01472-5 · Cited by 84 · see citing works
Schiffenbauer, J., Streit, W. J., Butfiloski, E. J., Labow, M., Edwards, C. K., & Moldawer, L. L. (2000) · Clinical Immunology · doi:10.1006/clim.2000.4851 · Cited by 84 · see citing works
Raine, C. S., Bonetti, B., & Cannella, B. (1998) · PubMed · Cited by 75 · see citing works
Differential Oligodendroglial Expression of the Tumor Necrosis Factor Receptors In Vivo and In Vitro
Tchélingérian, J., Monge, M., Saux, F. L., Zalc, B., & Jacque, C. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65052377.x · Cited by 61 · see citing works
Croxford, J. L., Triantaphyllopoulos, K. A., Neve, R. M., Feldmann, M., Chernajovsky, Y., & Baker, D. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2776 · Cited by 40 · see citing works
Tansey, F. A., Zhang, H., & Cammer, W. (1997) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815240 · Cited by 10 · see citing works
- Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
TNF-mediated inflammatory disease
Bradley, Jr. (2008) · The Journal of Pathology · doi:10.1002/path.2287 · Cited by 2,094 · see citing works
Remyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544 · see citing works
Microglia Biology: One Century of Evolving Concepts
Prinz, M., Jung, S., & Priller, J. (2019) · Cell · doi:10.1016/j.cell.2019.08.053 · Cited by 1,525 · see citing works
Tumor Necrosis Factor-α Signaling in Macrophages
Parameswaran, N., & Patial, S. (2010) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v20.i2.10 · Cited by 1,451 · see citing works
Repertoire of microglial and macrophage responses after spinal cord injury
David, S., & Kroner, A. (2011) · Nature reviews. Neuroscience · doi:10.1038/nrn3053 · Cited by 1,437 · see citing works
TNF biology, pathogenic mechanisms and emerging therapeutic strategies
Kalliolias, G. D., & Ivashkiv, L. B. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.169 · Cited by 1,390 · see citing works
The Mystery and Magic of Glia: A Perspective on Their Roles in Health and Disease
Barres, B. A. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.013 · Cited by 1,352 · see citing works
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265 · see citing works
T cell subsets and their signature cytokines in autoimmune and inflammatory diseases
Raphael, I., Nalawade, S. A., Eagar, T. N., & Forsthuber, T. G. (2014) · Cytokine · doi:10.1016/j.cyto.2014.09.011 · Cited by 1,177 · see citing works
Debris clearance by microglia: an essential link between degeneration and regeneration
Neumann, H., Kotter, M. R., & Franklin, R. J. M. (2008) · Brain · doi:10.1093/brain/awn109 · Cited by 1,111 · see citing works
STAT3 is a Critical Regulator of Astrogliosis and Scar Formation after Spinal Cord Injury
Herrmann, J. E., Imura, T., Song, B., Qi, J., Ao, Y., Nguyen, T. K., Korsak, R. A., Takeda, K., Akira, S., & Sofroniew, M. V. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1709-08.2008 · Cited by 958 · see citing works
Kuhlmann, T., Miron, V., Cuo, Q., Wegner, C., Antel, J., & Bruck, W. (2008) · Brain · doi:10.1093/brain/awn096 · Cited by 864 · see citing works
Regulation of innate immune responses in the brain
Rivest, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2565 · Cited by 843 · see citing works
McCoy, M. K., & Tansey, M. G. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-45 · Cited by 843 · see citing works
Why does remyelination fail in multiple sclerosis?
Franklin, R. J. M. (2002) · Nature reviews. Neuroscience · doi:10.1038/nrn917 · Cited by 837 · see citing works
The role of inflammation in perinatal brain injury
Hagberg, H., Mallard, C. E., Ferriero, D. M., Vannucci, S. J., Levison, S. W., Vexler, Z. S., & Gressèns, P. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.13 · Cited by 831 · see citing works
Interrelation of Oxidative Stress and Inflammation in Neurodegenerative Disease: Role of TNF
Fischer, R., & Maier, O. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/610813 · Cited by 744 · see citing works
Innate immunity: the missing link in neuroprotection and neurodegeneration?
Nguyen, M. D., Julien, J., & Rivest, S. (2002) · Nature reviews. Neuroscience · doi:10.1038/nrn752 · Cited by 698 · see citing works
Oligodendrocytes in development, myelin generation and beyond
Kuhn, S., Gritti, L., Crooks, D., & Dombrowski, Y. (2019) · Cells · doi:10.3390/cells8111424 · Cited by 625 · see citing works
Kim, Y.-K., Na, K.-S., Myint, A.-M., & Leonard, B. E. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.06.008 · Cited by 620 · see citing works
Inefficient clearance of myelin debris by microglia impairs remyelinating processes
Lampron, A., Larochelle, A., Laflamme, N., Préfontaine, P., Plante, M.-M., Sánchez, M. G., Yong, V. W., Stys, P. K., Tremblay, M.-È., & Rivest, S. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141656 · Cited by 595 · see citing works
Progressive multiple sclerosis: from pathogenic mechanisms to treatment
Correale, J. D., Gaitán, M. I., Ysrraelit, M. C., & Fiol, M. P. (2016) · Brain · doi:10.1093/brain/aww258 · Cited by 583 · see citing works
Elaborate interactions between the immune and nervous systems
Steinman, L. (2004) · Nature Immunology · doi:10.1038/ni1078 · Cited by 556 · see citing works
Alarmins: awaiting a clinical response
Chan, J. K.-K., Roth, J., Oppenheim, J. J., Tracey, K. J., Vogl, T., Feldmann, M., Horwood, N. J., & Nanchahal, J. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62423 · Cited by 507 · see citing works
TNF and its receptors in the CNS: The essential, the desirable and the deleterious effects
Probert, L. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.06.038 · Cited by 497 · see citing works
CNS inflammation and neurodegeneration
Chitnis, T., & Weiner, H. L. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90609 · Cited by 484 · see citing works
Steinman, L., & Zamvil, S. S. (2006) · Annals of Neurology · doi:10.1002/ana.20913 · Cited by 479 · see citing works
The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses
Ward-Kavanagh, L. K., Lin, W. W., Šedý, J. R., & Ware, C. F. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.019 · Cited by 463 · see citing works
Eiger, a TNF superfamily ligand that triggers the Drosophila JNK pathway
Igaki, T., Kanda, H., Yamamoto‐Goto, Y., Kanuka, H., Kuranaga, E., Aigaki, T., & Miura, M. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf306 · Cited by 462 · see citing works
Iosif, R. E., Ekdahl, C. T., Ahlenius, H., Pronk, C. J., Bonde, S., Kokaia, Z., Jacobsen, S. E. W., & Lindvall, O. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2723-06.2006 · Cited by 462 · see citing works
Degenerative and regenerative mechanisms governing spinal cord injury
Profyris, C., Cheema, S. S., Zang, D., Azari, M. F., Boyle, K., & Petratos, S. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.11.015 · Cited by 457 · see citing works
The life, death, and replacement of oligodendrocytes in the adult CNS
McTigue, D. M., & Tripathi, R. B. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05570.x · Cited by 455 · see citing works
TNF receptor 2 pathway: drug target for autoimmune diseases
Faustman, D., & Davis, M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3030 · Cited by 446 · see citing works
Chomiak, T., & Hu, B. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007754 · Cited by 446 · see citing works
Oligodendrocyte‐microglia cross‐talk in the central nervous system
Peferoen, L., Kipp, M., van der Valk, P., van Noort, J. M., & Amor, S. (2014) · Immunology · doi:10.1111/imm.12163 · Cited by 438 · see citing works
Kirby, L., Jin, J., Cardona, J. G., Smith, M. D., Martin, K. A., Wang, J., Strasburger, H., Herbst, L., Alexis, M., Karnell, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11638-3 · Cited by 436 · see citing works
Praet, J., Guglielmetti, C., Berneman, Z., Van der Linden, A., & Ponsaerts, P. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.10.004 · Cited by 435 · see citing works
The HPA – Immune Axis and the Immunomodulatory Actions of Glucocorticoids in the Brain
Bellavance, M.-A., & Rivest, S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00136 · Cited by 419 · see citing works
Remyelination capacity of the MS brain decreases with disease chronicity
Goldschmidt, T., Antel, J., König, F. B., Brück, W., & Kuhlmann, T. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a8260a · Cited by 411 · see citing works
Targeting RIPK1 for the treatment of human diseases
Degterev, A., Ofengeim, D., & Yuan, J. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901179116 · Cited by 410 · see citing works
Role of TNF–TNF Receptor 2 Signal in Regulatory T Cells and Its Therapeutic Implications
Yang, S., Wang, J., Brand, D. D., & Zheng, S. G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00784 · Cited by 405 · see citing works
NLR members NLRC4 and NLRP3 mediate sterile inflammasome activation in microglia and astrocytes
Freeman, L., Guo, H., David, C. N., Brickey, W. J., Jha, S., & Ting, J. P.-Y. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20150237 · Cited by 397 · see citing works
Self-citationSuzuki, T., Hide, I., Ido, K., Kohsaka, S., Inoue, K., & Nakata, Y. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3792-03.2004 · Cited by 394 · see citing works
Park, J. B., Yiu, G. C., Kaneko, S., Wang, J., Chang, J., & He, Z. (2005) · Neuron · doi:10.1016/j.neuron.2004.12.040 · Cited by 388 · see citing works
The pro-remyelination properties of microglia in the central nervous system
Lloyd, A. F., & Miron, V. E. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0184-2 · Cited by 381 · see citing works
The mucosal immune system: master regulator of bidirectional gut-brain communications
Powell, N., Walker, M. M., & Talley, N. J. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.191 · Cited by 379 · see citing works
Animal models of multiple sclerosis: the good, the bad and the bottom line
Ransohoff, R. M. (2012) · Nature Neuroscience · doi:10.1038/nn.3168 · Cited by 379 · see citing works
Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned
Gudi, V., Gingele, S., Skripuletz, T., & Stangel, M. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00073 · Cited by 375 · see citing works
Neuroprotective role of the innate immune system by microglia
Glezer, I., Simard, A. R., & Rivest, S. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.02.055 · Cited by 371 · see citing works
Montgomery, S. L., & Bowers, W. J. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9287-2 · Cited by 365 · see citing works
Identification of a microglia phenotype supportive of remyelination
Olah, M., Amor, S., Brouwer, N., Vinet, J., Eggen, B., Biber, K., & Boddeke, H. W. G. M. (2012) · Glia · doi:10.1002/glia.21266 · Cited by 358 · see citing works
McCoy, M. K., Martinez, T. N., Ruhn, K. A., Szymkowski, D. E., Smith, C. G., Botterman, B. R., Tansey, K. E., & Tansey, M. G. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1504-06.2006 · Cited by 355 · see citing works
Remyelination in multiple sclerosis: From basic science to clinical translation
Lubetzki, C., Zalc, B., Williams, A., Stadelmann, C., & Stankoff, B. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30140-x · Cited by 350 · see citing works
Closed head injury—an inflammatory disease?
Schmidt, O. I., Heyde, C. E., Ertel, W., & Stahel, P. F. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.028 · Cited by 346 · see citing works
Inflammatory Cytokine TNFα Promotes the Long-Term Expansion of Primary Hepatocytes in 3D Culture
Peng, W. C., Logan, C. Y., Fish, M., Anbarchian, T., Aguisanda, F., Álvarez-Varela, A., Wu, P., Jin, Y., Zhu, J., Li, B., et al. (2018) · Cell · doi:10.1016/j.cell.2018.11.012 · Cited by 331 · see citing works
Kotter, M. R., Zhao, C., van Rooijen, N., & Franklin, R. J. M. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.09.019 · Cited by 331 · see citing works
The function of microglia through purinergic receptors: Neuropathic pain and cytokine release
Inoue, K. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.07.001 · Cited by 326 · see citing works
Myelin Regeneration: A Recapitulation of Development?
Fancy, S. P. J., Chan, J. R., Baranzini, S. E., Franklin, R. J. M., & Rowitch, D. H. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113629 · Cited by 321 · see citing works
Neuroplastic changes in depression: A role for the immune system
Eyre, H., & Baune, B. T. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.03.019 · Cited by 319 · see citing works
CNS Demyelination with TNF-α Blockers
Kemanetzoglou, E., & Andreadou, E. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0742-1 · Cited by 318 · see citing works
Peluso, M. J., Lu, S., Tang, A. F., Durstenfeld, M. S., Ho, H.-E., Goldberg, S. A., Forman, C. A., Munter, S. E., Hoh, R., Tai, V., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab490 · Cited by 318 · see citing works
Jha, S., Srivastava, S. Y., Brickey, W. J., Iocca, H., Toews, A., Morrison, J. P., Chen, V. S., Gris, D., Matsushima, G. K., & Ting, J. P.-Y. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4088-10.2010 · Cited by 310 · see citing works
Self-citationTheiler's Virus Infection: a Model for Multiple Sclerosis
Oleszak, E. L., Chang, J. R., Friedman, H. P., Katsetos, C. D., & Platsoucas, C. D. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.1.174-207.2004 · Cited by 307 · see citing works
Fancy, S. P. J., Zhao, C., & Franklin, R. J. M. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.06.015 · Cited by 302 · see citing works
Astrocytes—Friends or foes in multiple sclerosis?
Williams, A., Piaton, G., & Lubetzki, C. (2007) · Glia · doi:10.1002/glia.20546 · Cited by 301 · see citing works
Cytokines: Powerful Regulators of Glial Cell Activation
John, G. R., Lee, S. C., & Brosnan, C. F. (2003) · The Neuroscientist · doi:10.1177/1073858402239587 · Cited by 299 · see citing works
Kigerl, K. A., Lai, W., Rivest, S., Hart, R. P., Satoskar, A. R., & Popovich, P. G. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04524.x · Cited by 298 · see citing works
Chen, X., Wu, X., Zhou, Q., Howard, O. M. Z., Netea, M. G., & Oppenheim, J. J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1202659 · Cited by 291 · see citing works
Programming inflammatory cell death for therapy
Christgen, S. L., Tweedell, R. E., & Kanneganti, T. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108010 · Cited by 290 · see citing works
Burkly, L. C., Michaelson, J. S., Hahm, K., Jakubowski, A., & Zheng, T. S. (2007) · Cytokine · doi:10.1016/j.cyto.2007.09.007 · Cited by 285 · see citing works
Ben‐Hur, T., Menachem-Zidon, O. B., Furer, V. L., Einstein, O., Mizrachi‐Kol, R., & Grigoriadis, N. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00218-5 · Cited by 283 · see citing works
Remyelination in Experimental Models of Toxin-Induced Demyelination
Blakemore, W. F., & Franklin, R. J. M. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-73677-6_8 · Cited by 275 · see citing works
Cortical Demyelination Is Prominent in the Murine Cuprizone Model and Is Strain-Dependent
Skripuletz, T., Lindner, M., Kotsiari, A., Garde, N., Fokuhl, J., Linsmeier, F., Trebst, C., & Stangel, M. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070850 · Cited by 271 · see citing works
Desai, M. K., Sudol, K. L., Janelsins, M. C., Mastrangelo, M. A., Frazer, M. E., & Bowers, W. J. (2009) · Glia · doi:10.1002/glia.20734 · Cited by 266 · see citing works
Up-regulation of BDNF in Astrocytes by TNF-α: A Case for the Neuroprotective Role of Cytokine
Saha, R. N., Liu, X., & Pahan, K. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9020-8 · Cited by 258 · see citing works
The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets
Myers, R. R., Campana, W. M., & Shubayev, V. I. (2006) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03637-8 · Cited by 256 · see citing works
Yang, L., Lindholm, K., Konishi, Y., Li, R., & Shen, Y. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03025.2002 · Cited by 255 · see citing works
The role of the purinergic P2X7 receptor in inflammation
Lister, M. F., Sharkey, J., Sawatzky, D. A., Hodgkiss, J. P., Davidson, D. J., Rossi, A. G., & Finlayson, K. (2007) · Journal of Inflammation · doi:10.1186/1476-9255-4-5 · Cited by 255 · see citing works
Tumor necrosis factor receptor cross‐talk
Naudé, P. J. W., den Boer, J. A., Luiten, P. G. M., & Eisel, U. L. M. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08017.x · Cited by 253 · see citing works
Iron in multiple sclerosis: roles in neurodegeneration and repair
Stephenson, E. L., Nathoo, N., Mahjoub, Y., Dunn, J. F., & Yong, V. W. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.118 · Cited by 248 · see citing works
TNFα in synaptic function: switching gears
Santello, M., & Volterra, A. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.06.001 · Cited by 245 · see citing works
Selective Targeting of TNF Receptors as a Novel Therapeutic Approach
Fischer, R., Kontermann, R. E., & Pfizenmaier, K. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00401 · Cited by 243 · see citing works
Role of tumor necrosis factor-alpha in the central nervous system: a focus on autoimmune disorders
Caldito, N. G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1213448 · Cited by 240 · see citing works
Chen, J., Sonsalla, P. K., Pedata, F., Melani, A., Domenici, M. R., Popoli, P., Geiger, J. D., Lopes, L. V., & de Mendonça, A. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.09.002 · Cited by 238 · see citing works
Astrocytes: Conductors of the Alzheimer disease neuroinflammatory symphony
Medeiros, R., & LaFerla, F. M. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.10.007 · Cited by 236 · see citing works
Cells of the oligodendroglial lineage, myelination, and remyelination
Miron, V. E., Kuhlmann, T., & Antel, J. P. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.09.010 · Cited by 236 · see citing works
Cell migration in the normal and pathological postnatal mammalian brain
Cayre, M., Canoll, P., & Goldman, J. E. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.02.001 · Cited by 235 · see citing works
Immune Influence on Adult Neural Stem Cell Regulation and Function
Carpentier, P. A., & Palmer, T. D. (2009) · Neuron · doi:10.1016/j.neuron.2009.08.038 · Cited by 235 · see citing works
Microglial Recruitment, Activation, and Proliferation in Response to Primary Demyelination
Remington, L. T., Babcock, A. A., Zehntner, S. P., & Owens, T. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060783 · Cited by 234 · see citing works
Zirngibl, M., Assinck, P., Sizov, A., Caprariello, A. V., & Plemel, J. R. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00538-8 · Cited by 233 · see citing works
White Matter Plasticity and Enhanced Remyelination in the Maternal CNS
Gregg, C., Shikar, V., Larsen, P. H., Mak, G. K., Chojnacki, A. K., Yong, V. W., & Weiss, S. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4441-06.2007 · Cited by 231 · see citing works
Glial Cells Shape Pathology and Repair After Spinal Cord Injury
Gaudet, A. D., & Fonken, L. K. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-0630-7 · Cited by 232 · see citing works
CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination
Patel, J. R., McCandless, E. E., Dorsey, D., & Klein, R. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006301107 · Cited by 231 · see citing works
Multiple Sclerosis: Deeper Understanding of Its Pathogenesis Reveals New Targets for Therapy
Steinman, L., Martinꝉ, R., Bernard, C. C. A., Conlon, P. J., & Oksenberg, J. R. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142913 · Cited by 230 · see citing works
Butyrate suppresses demyelination and enhances remyelination
Chen, T., Noto, D., Hoshino, Y., Mizuno, M., & Miyake, S. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1552-y · Cited by 229 · see citing works
Quantifying the early stages of remyelination following cuprizone-induced demyelination
Stidworthy, M. F., Genoud, S., Suter, U., Mantei, N., & Franklin, R. J. M. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00032.x · Cited by 224 · see citing works
Besser, M. J., Ganor, Y., & Levite, M. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.07.013 · Cited by 221 · see citing works
Bernardino, L., Agasse, F., Silva, B., Ferreira, R., Grade, S., & Malva, J. O. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0914 · Cited by 220 · see citing works
Glial Development: The Crossroads of Regeneration and Repair in the CNS
Gallo, V., & Deneen, B. (2014) · Neuron · doi:10.1016/j.neuron.2014.06.010 · Cited by 219 · see citing works
Cytokines in multiple sclerosis: from bench to bedside
Imitola, J., Chitnis, T., & Khoury, S. J. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.11.007 · Cited by 218 · see citing works
- Authors
- Arnett, H. A., Mason, J., Marino, M., Suzuki, K., Matsushima, G. K., & Ting, J. P.-Y.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Ting, Jenny P.-Y.
- Venue
- Nature Neuroscience
- Published
- 2001-10-15
- Volume
- 4
- Issue
- 11
- Pages
- 1116-1122
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W1509596990
- Cited by
- 1,012
- References
- 48
- Citations by year
- 2026: 26 · 2025: 30 · 2024: 37 · 2023: 39 · 2022: 40 · 2021: 43 · 2020: 46 · 2019: 43 · 2018: 34 · 2017: 40 · 2016: 36 · 2015: 45 · 2014: 46 · 2013: 45 · 2012: 51
- FWCI
- 7.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS34190, R01NS034190)
- Topics
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- TNF-α, remyelination, demyelination, oligodendrocyte progenitors, oligodendrocyte proliferation, TNF receptor 1, TNF receptor 2, cuprizone, oligodendrocyte precursor cells, demyelinating disease, central nervous system regeneration
- MeSH terms
- Animals, B-Lymphocytes, Brain Chemistry, Corpus Callosum, Cuprizone, Demyelinating Diseases, Disease Models, Animal, Humans, Immunohistochemistry, Macrophages, Male, Monoamine Oxidase Inhibitors, Myelin Sheath, Oligodendroglia, Stem Cells, Tumor Necrosis Factor-alpha, Antigens, CD, Up-Regulation, Apoptosis, Microglia, Receptors, Tumor Necrosis Factor, Mice, Knockout, In Situ Nick-End Labeling, Receptors, Tumor Necrosis Factor, Type I, Receptors, Tumor Necrosis Factor, Type II, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review